In vitro evaluation of the role of platelet-activating factor and interleukin-8 in Mannheimia haemolytica-induced bovine pulmonary endothelial cell injury

American Journal of Veterinary Research

Volumn 63, Issue 3, 2002, Pages 394-401

  McClenahan, David J ^a   Evanson, Oral A ^a   Weiss, Douglas J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; APAFANT; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 8; LACTOFERRIN; SUPEROXIDE; SYNTHETIC PEPTIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CATTLE DISEASE; CELL CULTURE; CELL DAMAGE; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; EVALUATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG CAPILLARY; LUNG ENDOTHELIUM; MACROPHAGE ACTIVATION; MANNHEIMIA HAEMOLYTICA; MONOCYTE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; SUPERNATANT; TISSUE CULTURE CELL;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; MANNHEIMIA; MANNHEIMIA HAEMOLYTICA; PASTEURELLA;

EID: 0036521404     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.394     Document Type: Article

References (67)

1. Griffen D. Economic impact associated with respiratory disease in beef cattle. Vet Clin North Am Food Anim Pract 1997;13:367-377.
2. Weekley LB, Veit HP, Eyre P. Bovine pneumonic pasteurellosis. Part I. Pathophysiology. Compend Contin Educ Pract Vet 1998; 20:S33-S46.
3. Fox ML, Thomson RG, Magwood SE. Pasteurella haemolytica of cattle: serotype, production of beta-galactosidase and antibacterial sensitivity. Can J Comp Med 1971;35:313-317.
4. Smith RA, Deyhle C Sr, Engler M, et al. Pasteurella haemolytica pneumonia, part 1. Agri-Pract 1994;15:5-7.
5. Fulton RW. Viruses associated with bovine respiratory diseases and infections, in Proceedings. 59th West Vet Conf 1987;17-31.
6. Kiorpes AL, Dubielzig RR, Beck KA. Enzootic pneumonia in calves: clinical and morphologic features. Compend Contin Educ Pract Vet 1988;10:248-257.
7. Rashid J, Weiss DJ, Bach R, et al. Role of tissue factor in intra-alveolar fibrin deposition and coagulopathy associated with pneumonic pasteurellosis in cattle. Am J Vet Res 1997;58:28-33.
8. Weiss DJ, Bauer MC, Whiteley LO, et al. Changes in blood and bronchoalveolar lavage fluid components in calves with experimentally induced pneumonic pasteurellosis. Am J Vet Res 1991;52:337-344.
9. Whitely LO, Maheswaran SK, Weiss DJ, et al. Alterations in pulmonary morphology and peripheral coagulation profiles caused by intratracheal inoculation of live and ultraviolet light-killed Pasteurella haemolytica A1 in calves. Vet Pathol 1991;28:275-285.
10. Maheswaran SK, Weiss DJ, Kannan MS, et al. Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Vet Immunol Immunopathol 1992;33:51-68.
11. Paulsen DB, Mosier DA, Clinkenbeard KD, et al. Direct effects of Pasteurella haemolytica lipopolysaccharide on bovine pulmonary endothelial cells in vitro. Am J Vet Res 1989;50:1633-1637.
12. Brieder MA, Walker RD, Hopkins FM, et al. Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Can J Vet Res 1988;52:205-209.
13. Morsey MA, Van-Kessel AG, Mori Y, et al. Cytokine profiles following interaction between bovine alveolar macrophages and Pasteurella haemolytica. Microb Pathog 1999;26:325-331.
14. Yang Z, Khemlani LS, Dean DF et al. Serum components enhance bacterial lipopolysaccharide-induced tissue factor expression and tumor necrosis factor-α secretion by bovine alveolar macrophages in vitro. J Leukoc Biol 1994;55:483-488.
15. Yoo HS, Maheswaran SK, Lin G, et al. Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide. Infect Immun 1995;63:381-388.
16. Czuprynski CJ, Hamilton HL, Noel EJ. Ingestion and killing of Pasteurella haemolytica A1 by bovine neutrophils. Vet Microbiol 1987;14:61-74.
17. Benson ML, Thomson RG, Valli VE. The bovine alveolar macrophage. II. In vitro studies with Pasteurella haemolytica. Can J Comp Med 1978;42:368-369.
18. Hsuan SL, Kannan MS, Jeyaseelan S, et al. Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-κB activation and calcium elevation. Microb Pathog 1999;26:263-273.
19. Kuijpers TW, Hakkert BC, Hoogerwerf M, et al. Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. J Immunol 1991;147:1369-1376.
20. McGill SN, Ahmed NA, Christou NV. Endothelial cells: role in infection and inflammation. World J Surg 1998;22:171-178.
21. Introna M, Mantovani A. Early activation signals in endothelial cells: stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997;17:423-428.
22. Topham MK, Carveth HJ, McIntyre TM, et al. Human endothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB J 1998;12:733-746.
23. Wang JH, Redmond HP, Watson RWG, et al. Mechanisms involved in the induction of human endothelial cell necrosis. Cell Immunol 1996;168:91-99.
24. Gill EA, Imaizumi T-A, Carveth H, et al. Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils. FASEB J 1998;12:673-684.
25. Slocombe RF, Malark J, Ingersoll R, et al. Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am J Vet Res 1985;46:2253-2258.
26. Renesto P, Vicart P, Paulin D, et al. Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. Br J Pharmacol 1996;117:902-906.
27. Franciose RJ, Moore EE, Moore FA, et al. Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism. J Surg Res 1996;61:459-462.
28. Bussolino F, Camussi G, Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J Biol Chem 1988;263:11856-11861.
29. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997;349:490-495.
30. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992;13:291-294.
31. Solomkin JS, Burnett RJ III, Cave CM, et al. A review: neutrophils, compartmentalized cytokine release, and lung injury Prog Surg 1995;20:77-90.
32. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci 1998;94:461-471.
33. Burgener I, Jungi TW, Zurbriggen A, et al. Dose-dependent priming or desensitization induced by chemotactic agents in chemiluminescence experiments with canine and human neutrophils. Vet Immunol Immunopathol 1998;66:11-24.
34. Pugin J, Widmer M-C, Kossodo S, et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999;20:458-464.
35. Brandolini L, Bertini R, Bizzarri C, et al. IL-1β primes IL-8 activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J Leukoc Biol 1996;59:427-434.
36. Mackarel AJ, Cottell DC, Russell KJ, et al. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol 1999;20:1209-1219.
37. Persson K, Larsson I, Sandgren CH. Effects of certain inflammatory mediators on bovine neutrophil migration in vivo and in vitro. Vet Immumol Immunopathol 1993;37:99-112.
38. Kuijpers TW, Hakkert BC, Hart MHL, et al. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 1992;117:565-572.
39. Caswell JL, Middleton DM, Sorden SD, et al. Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis. Vet Pathol 1998;35:124-131.
40. Macconi D, Foppolo M, Paris S, et al. PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am J Physiol 1994;269 C42-C47.
41. Owen CA, Campbell MA, Boukedes SS, et al. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. Am J Physiol 1997;272:L385-L393.
42. Swain SD, Bunger PL, Sipes KM, et al. Platelet-activating factor induces a concentration-dependent spectrum of functional responses in bovine neutrophils. J Leukoc Biol 1998;64:817-827.
43. Hill ME, Bird IN, Daniels RH, et al. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1β-treated endothelial monolayers. J Immunol 1994;153:3673-3682.
44. McClenahan DJ, Fagliari JJ, Evanson OA, et al. Role of platelet-activating factor in alveolar septal injury associated with experimentally induced pneumonic pasteurellosis in calves. Am J Vet Res 2000;61:248-254.
45. Roth JA, Kaeberle ML. Evaluation of bovine polymorphonuclear leukocyte function. Vet Immunol Immunopathol 1981;2:157-174.
46. Weiss DJ, Evanson OA, McClenahan DJ, et al. Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium. Infect Immun 2001;69:1002-1008.
47. 2 release by adherent neutrophil leukocytes. J Immunol 1995;154:1383-1390.
48. Hayashi S, Kurdowska A, Miller EJ, et al. Synthetic hexa-and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils. J Immunol 1995;154:814-824.
49. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bacteriocidal agent. J Clin Invest 1973;52:741-744.
50. Breider MA, Kumar S, Corstvet RE. Bovine pulmonary endothelial cell damage mediated by Pasteurella haemolytica pathogenic factors. Infect Immun 1990;58:1671-1677.
51. Maheswaran SK, Kannan MS, Weiss DJ, et al. Enhancement of neutrophil-mediated injury to bovine pulmonary endothelial cells by Pasteurella haemolytica leukotoxin. Infect Immun 1993;61:2618-2625.
52. Morsey MA, Popowych Y, Kowalski J, et al. Molecular cloning and expression of bovine interleukin-8. Microb Pathog 1996;20:203-212.
53. 2 integrins are not required for activation of bovine macrophages by lipopolysaccharide. Infect Immun 1997;65:3577-3584.
54. Vasselon T, Hailman E, Thieringer R, et al. Internalization of monomeric lipopolysaccharide occurs after transfer out of cell surface CD14. J Exp Med 1999;190:509-521.
55. Dahlberg PS, Acton RD, Battafarano RJ, et al. A novel endotoxin antagonist attenuates tumor necrosis Factor-α secretion. J Surg Res 1996;63:44-48.
56. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Invest Med 1994;42:640-650.
57. Harada A, Mukaida N, Matsushima K. Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases. Mol Med Today 1996:482-489.
58. Lorant DE, Topham MK, Whatley RE, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-570.
59. Marcus BC, Hynes KL, Gewertz BL. Loss of enclothelial barrier function requires neutrophil adhesion. Surgery 1997;122:420-426.
60. Yamamoto T, Kajikawa O, Martin TR, et al. The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. J Immunol 1998;161:5704-5709.
61. Miller EJ, Cohen AB, Peterson BT. Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflamm Res 1996;45:393-397.
62. McClenahan D, Fagliari J, Evanson O, et al. Role of inflammatory mediators in priming, activation, and deformability of bovine neutrophils. Am J Vet Res 2000;61:492-498.
63. Van Dervort AL, Charles L, Culpepper S, et al. Interleukin-8 priming of human neutrophils is not associated with persistently altered calcium fluxes but is additive with lipopolysaccharide. J Leukoc Biol 1998;64:511-518.
64. Chabot F, Mitchell JA, Gutterridge JMC, et al. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-757.
65. Lin CP, Lynch MC, Kochevar IE. Reactive oxidizing species produced near the plasma membrane induce apoptosis in bovine aorta endothelial cells. Exp Cell Res 2000;259:351-359.
66. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol 2001;280:C719-C741.
67. Ochoa L, Waypa G, Mahoney JR Jr, et al. Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability. Am J Respir Crit Care Med 1997;156:1247-1255.